Literature DB >> 9296327

Excretion of citalopram in breast milk.

O Spigset1, L Carieborg, R Ohman, A Norström.   

Abstract

AIMS: The objective of this study was to measure to secretion of the selective serotonin uptake inhibitor citalopram in breast milk.
METHODS: The excretion of citalopram in breast milk was studied at steady-state conditions in two patients with depression and in one healthy volunteer after ingestion of a single dose citalopram.
RESULTS: Milk/serum concentration ratios based on single pairs of samples from the two patients ranged from 1.16 to 1.88. Based on milk concentration data from the patients, the absolute dose ingested by a suckling infant would be 4.3-17.6 micrograms kg-1 day-1, and the relative dose 0.7-5.9% of the weight-adjusted maternal dose. Based on area-under-the-time-concentration curves from the healthy volunteer, the milk/serum ratio was 1.00, the absolute dose to the infant during steady-state conditions would be 11.2 micrograms kg-1 day-1 and the relative dose 1.8% of the weight-adjusted maternal dose.
CONCLUSION: The study shows that the relative dose to a suckling infant is close to that reported for fluoxetine, and higher than reported for fluvoxamine, paroxetine and sertraline.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9296327      PMCID: PMC2042842          DOI: 10.1046/j.1365-2125.1997.t01-1-00576.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

Review 1.  Etiology and treatment of postpartum depression.

Authors:  Deborah Lynne Flores; Victoria C Hendrick
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 2.  Neonatal exposure to drugs in breast milk.

Authors:  Patrick J McNamara; Maggie Abbassi
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

Review 3.  Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index.

Authors:  Salvatore Gentile
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

4.  Transfer of escitalopram and its metabolite demethylescitalopram into breastmilk.

Authors:  Jonathan Rampono; L Peter Hackett; Judith H Kristensen; Rolland Kohan; Madhu Page-Sharp; Kenneth F Ilett
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

Review 5.  Benefits and risks to mother and infant of drug treatment for postnatal depression.

Authors:  Shaila Misri; Xanthoula Kostaras
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants.

Authors:  J Rampono; J H Kristensen; L P Hackett; M Paech; R Kohan; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

Review 7.  Citalopram--a review of pharmacological and clinical effects.

Authors:  K Bezchlibnyk-Butler; I Aleksic; S H Kennedy
Journal:  J Psychiatry Neurosci       Date:  2000-05       Impact factor: 6.186

Review 8.  The safety of newer antidepressants in pregnancy and breastfeeding.

Authors:  Salvatore Gentile
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 9.  Use of psychotropic medications in treating mood disorders during lactation : practical recommendations.

Authors:  Malin Eberhard-Gran; Anne Eskild; Stein Opjordsmoen
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

10.  Antidepressant transfer into amniotic fluid, umbilical cord blood & breast milk: A systematic review & combined analysis.

Authors:  Georgios Schoretsanitis; Andreas A Westin; Julia C Stingl; Kristina M Deligiannidis; Michael Paulzen; Olav Spigset
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-01-02       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.